Publikace detail

Risk Management for Serum Paraprotein Analysis in the Clinical Biochemistry Laboratory

Autoři: Kašparová Michaela | Červenková Zuzana

Rok: 2024

Druh publikace: ostatní - článek ve sborníku

Název zdroje: MEKON 2024 : sborník VIII. ročníku mezinárodní konference Kvalita a její perspektivy : 4 pílíře péče

Název nakladatele: Univerzita Pardubice

Místo vydání: Pardubice

Strana od-do: nestránkováno

Tituly:

Jazyk	Název	Abstrakt	Klíčová slova
eng	Risk Management for Serum Paraprotein Analysis in the Clinical Biochemistry Laboratory	Introduction: The risk management process is an essential part of the quality management system in a clinical biochemistry laboratory. Sample testing is a complex process in which errors can occur at any stage of the laboratory process. This study focuses on risk management in serum paraprotein analysis. Aim: The aim of the study was to perform a risk analysis associated with the process of serum paraprotein analysis in a clinical biochemistry laboratory. Method: In this study was used the proactive risk analysis method FMEA (Failure Mode and Effects Analysis). FMEA includes the analysis of possible failures, determination of the probability of occurrence, severity of their consequences and probability of detection. Based on this information, risk reduction measures are proposed. Results: Potential risks associated with serum paraprotein analysis have been identified. These risks were assessed and prioritised. For the most serious risks, measures to eliminate them were proposed. Conclusion: The results of this study provide a comprehensive and practically applicable overview of risk factors and recommendations for improving the quality and safety of laboratory analyses of serum paraprotein in the clinical biochemistry laboratory.	clinical biochemistry; electrophoresis; FMEA; paraprotein; risk management

Search